Option chain shows key data for Precision Optics Corp's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Precision Optics Corp.

Precision Optics Corp (NASDAQ:POCI) Stock, Option Chain

Precision Optics Corp

Precision Optics Corp Inc is engaged in designing, developing, and manufacturing advanced optical instruments. It manufactures medical products such as endoscopes and endocouplers which incorporate various optical technologies for use in a variety of minimally invasive surgical and diagnostic procedures. The company also produces endoscopes for various applications as well as designs and manufactures custom optical medical devices to satisfy customers' specific requirements. In addition, the company manufactures and sells components and assemblies specially designed for industrial and military use. The company earns the majority of its revenue from the United States.

Precision Optics Corporation, Inc. - Common stock

Precision Optics Corp Inc

News

Contracts

POCI

Precision Optics Secures Initial $340K Production Order From A Large, Global Medical Device Company For New Single-use Ophthalmic Endoscope

Precision Optics Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/POCI#NASDAQ">POCI</a>) reported quarterly losses of $(0.21) per share. This is a 162.5 percent decrease over losses of $(0.08) per share from the same period last year. The company reported $4.20 million in sales this quarter. This is a 2.88 percent decrease over sales of $4.32 million the same period last year.

Earnings

Precision Optics Corp Q1 EPS $(0.21) Down From $(0.08) YoY, Sales $4.20M Down From $4.32M YoY

AFMD

AGAE

AIRI

AKYA

AMAT

AQMS

AREC

ASND

ASTS

AZUL

BENF

BILI

BIOR

Bakkt Holdings, Inc. Class A Common Stock

BKKT

BKTI

BKYI

BLUE

BNAI

BNZI

BRAG

BTAI

CASI

CELC

CINT

Chemomab Therapeutics Ltd. - American Depositary Shares

CMMB

CNVS

CRIS

CWCO

DARE

DBGI

DESP

DFLI

DLPN

DMRC

DNMR

DPRO

DTST

EAST

EFXT

ELUT

EWCZ

FLNT

FTLF

GAMB

GAME

GCTS

GDEV

GLOB

HYLN

IMCC

INKT

INTR

ITRM

IVVD

IZEA

LCTX

LIQT

LOCL

LUNR

MITQ

MOVE

MSGM

MUFG

NICE

NOMD

NTES

OCFT

OCUL

OKLO

ONEW

ORGN

PDSB

PHGE

POST

Earnings Scheduled For November 14, 2024

Biotech

General

Precision Optics Customer Receives FDA 510(k) Clearance

Precision Optics Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/POCI#NASDAQ">POCI</a>) reported quarterly losses of $(0.23) per share. This is a 1050 percent decrease over losses of $(0.02) per share from the same period last year. The company reported $4.72 million in sales this quarter. This is a 6.13 percent decrease over sales of $5.02 million the same period last year.

Precision Optics Corp Q4 EPS $(0.23) Down From $(0.02) YoY, Sales $4.72M Down From $5.02M YoY

WIIM

Precision Optics shares are trading lower after the company announced a $1.4 million registered direct offering.

Offerings

Precision Optics Prices $1.4M Registered Direct Offering

Precision Optics Corporation Inc Files For Mixed Shelf Of Up To $75M

Precision Optics Q3 2024 EPS $(0.05) Up From $(0.07) YoY; Revenue $5.242M Up From $5.048M YoY

Precision Optics Corporation, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/POCI#NASDAQ">POCI</a>), a leading designer and manufacturer of advanced optical instruments for the medical and defense industries, today announced a $9 million production order from a leading surgical company to supply single-use endoscope assemblies used in their cystoscopy surgery system. The assembly draws on POC's unique micro-optics and digital imaging technologies. This is the largest order POC has ever received and illustrates the opportunities that single-use applications provide to the Company. &nbsp;
Production deliveries are scheduled to begin July 2024 and proceed over several quarters. The Company presently estimates approximately $2.2 million in deliveries during its fiscal year ended June 2025, $4.6 million in fiscal 2026, and the remainder in the first half of fiscal 2027. Precision Optics has been performing engineering work for this customer and produced a limited number of units for testing and regulatory purposes. The Company expects a related $0.5 million order for related specialty engineering work over the next six months, bringing the total order value to approximately $9.5 million.

Precision Optics Announces Record $9M Production Order For High Volume Single-Use Cystoscopy Surgery Program; Expects A Related $0.5M Order For Related Specialty Engineering Work Over The Next Six Months, Bringing The Total Order Value To ~$9.5M

Precision Optics Wins $1.26M Follow On Production Order From Defense Company

Precision Optics Corporation, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/POCI#NASDAQ">POCI</a>), a leading designer and manufacturer of advanced optical instruments for the medical and defense industries, today announced it has received a $720,000 follow on production order from a top tier defense/aerospace company addressing a commercial application that leverages the Company's proprietary manufacturing technology developed for high precision micro-optics systems. &nbsp;
The Company received an initial $680,000 production order as of September 2023, and $517,000 in follow on production orders in November and December 2023. With today's announcement, total production orders for this leading-edge application now total more than $1.9 million. All orders currently received for this program are expected to be delivered by August 2024.
"Precision Optics continues to be at the forefront of innovation, helping yet another of the world's leading defense and aerospace companies develop next generation solutions," commented Dr. Joe Forkey, CEO of Precision Optics. "The optical assembly we developed for this program met the high-performance requirements necessary to support our customer's product, leading to multiple follow-on orders that will be delivered in the near-term. This program, coupled with others for which we have recently received manufacturing orders, gives us confidence that we will see strong sequential revenue growth throughout the remainder of fiscal year 2024. Importantly, based on customer discussions, we anticipate continuing order volumes for the next fiscal year and beyond. We believe our success here bodes well for our continued expansion efforts in the defense and aerospace market."

Precision Optics Announces Receipt Of $720,000 Follow-On Production Order From Top Tier Defense/Aerospace CustomerFfor New Optical Application

Precision Optics Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/POCI#NASDAQ">POCI</a>) reported quarterly losses of $(0.13) per share. This is a 218.18 percent decrease over earnings of $0.11 per share from the same period last year. The company reported $4.82 million in sales this quarter. This is a 18.06 percent decrease over sales of $5.89 million the same period last year.

Precision Optics Corp Q2 EPS $(0.13) Down From $0.11 YoY, Sales $4.82M Down From $5.89M YoY

ACGL

ADPT

AEMD

AMWL

ATEX

ATMU

ATUS

AVNT

AVTR

AYTU

BLIN

BXMT

BYRN

CCRD

CEVA

CHEF

CNDT

CNHI

CNXN

CRWS

CSCO

CSPI

EPRT

EQIX

FBRT

FCPT

FROG

FSLY

GLDD

GNRC

GOLD

GPMT

HCSG

HUBS

INFA

ISSC

KRNT

MCRI

MMLP

NATL

NMIH

NRDS

NTST

PEGA

PGRE

PLMR

PTEN

PYPD

QIPT

RBBN

Earnings Scheduled For February 14, 2024

Precision Optics Signs Production And Technology Licensing Agreement With A Surgical Robotics Company To Supply A Single-Use Cystoscopy Robotic Surgery Program

Precision Optics Receives Initial Purchase Order Against $1.4M Development Program

Precision Optics Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/POCI#NASDAQ">POCI</a>) reported quarterly losses of $(0.08) per share. This is a 166.67 percent decrease over losses of $(0.03) per share from the same period last year. The company reported $4.32 million in sales this quarter. This is a 15.02 percent decrease over sales of $5.09 million the same period last year.

Precision Optics Corp Q1 EPS $(0.08) Down From $(0.03) YoY, Sales $4.32M Down From $5.09M YoY

Precision Optics Q1 Revenue $4.3M, Down 15% YoY; EPS $(0.08)

Precision Optics Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/POCI#NASDAQ">POCI</a>) reported quarterly losses of $(0.02) per share. The company reported $5.02 million in sales this quarter.

Precision Optics Corp Q4 EPS $(0.02), Sales $5.02M

<h3>Companies Reporting Before The Bell</h3>
&bull; CarMax (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KMX#NYSE">KMX</a>) is projected to report quarterly earnings at $0.78 per share on revenue of $7.03 billion.
&bull; Accenture (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ACN#NYSE">ACN</a>) is projected to report quarterly earnings at $2.66 per share on revenue of $16.07 billion.
&bull; Renalytix (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RNLX#NASDAQ">RNLX</a>) is estimated to report quarterly loss at $0.13 per share on revenue of $720 thousand.
&bull; Palatin Techs (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/PTN#AMEX">PTN</a>) is likely to report quarterly loss at $0.56 per share on revenue of $1.37 million.
&bull; Jabil (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JBL#NYSE">JBL</a>) is likely to report quarterly earnings at $2.32 per share on revenue of $8.54 billion.
<h3>Companies Reporting After The Bell</h3>
&bull; Nike (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NKE#NYSE">NKE</a>) is expected to report quarterly earnings at $0.70 per share on revenue of $12.26 billion.
&bull; Vail Resorts (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MTN#NYSE">MTN</a>) is expected to report quarterly loss at $3.26 per share on revenue of $283.20 million.
&bull; Inventiva (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IVA#NASDAQ">IVA</a>) is projected to report earnings for its first quarter.
&bull; Precision Optics Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/POCI#NASDAQ">POCI</a>) is projected to report earnings for its fourth quarter.
&bull; Park City Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PCYG#NASDAQ">PCYG</a>) is estimated to report earnings for its fourth quarter.
&bull; BlackBerry (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BB#NYSE">BB</a>) is projected to report quarterly loss at $0.06 per share on revenue of $132.03 million.
&bull; Glimpse Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRAR#NASDAQ">VRAR</a>) is estimated to report quarterly loss at $0.14 per share on revenue of $4.00 million.
&bull; Treasure Global (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TGL#NASDAQ">TGL</a>) is estimated to report earnings for its fourth quarter.
This article was generated by Benzinga&#39;s automated content engine and reviewed by an editor.

PCYG

RNLX

VRAR

Earnings Scheduled For September 28, 2023

Precision Optics Corporation (POCI) has issued an update. Jeffrey L. DiRubio, Senior VP of Sales and Marketing at Precision Optics Corporation, res...

Precision Optics Senior VP Transitions to Consultative Role

Precision Optics announces pricing of $1.4M registered direct offering of common stock

Earnings week ahead: Nike, Carnival, Constellation Brands, and more

Precision Optics GAAP EPS of -$0.23, revenue of $4.72M

Precision Optics Corporation, Inc. (POCI) Q4 2024 Earnings Call Transcript

Precision Optics (POCI) announced that its customer, a surgical robotics company focused on transformative solutions in urology, recently announced...

Precision Optics announces its customer has received FDA 510k clearance

Precision Optics GAAP EPS of -$0.21, revenue of $4.19M

Precision Optics (POCI) announced an initial $340,000 production order from a large, global medical device company to provide initial stocking quan...

Precision Optics announces $340,000 production order from medical device company

Precision Optics Corporation, Inc. (POCI) Q1 2025 Earnings Call Transcript

Precision Optics Corporation, Inc. ( ($POCI) ) has released its Q1 earnings. Here is a breakdown of the information Precision Optics Corporation, I...

Precision Optics Corporation Reports Challenging Quarter

AIXI

ANGO

APOG

CALM

LEVI

LFCR

MESA

MLEC

NEOV

PAYX

STBX

TRAK

UNFI

VLGEA

WKEY

Health Care

Precision Optics to Participate in the Lytham Partners Spring 2024 Investor Conference on May 30, 2024

Comments

Precision Optics Corp

Precision Optics Corp (POCI) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga